We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current APGE market cap is 2.79B. The company's latest EPS is USD -1.4353 and P/E is -33.21.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.31M | -42.6M | -38.18M | -44.12M | -58.69M |
| Net Income | -20.84M | -31.74M | -32.09M | -33.82M | -49.02M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 0 |
| Operating Income | -93M |
| Net Income | -83.99M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | |||||
| Total Assets | 426.42M | 401.4M | 823.66M | 800.66M | 776.29M |
| Total Liabilities | 17.18M | 21.49M | 22.18M | 27.02M | 41.88M |
| Total Equity | 409.24M | 379.91M | 801.48M | 773.64M | 734.4M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 401.4M |
| Total Liabilities | 21.49M |
| Total Equity | 379.91M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | |||||
| Operating | -45.01M | -74.76M | -31.64M | -60.94M | -103.46M |
| Investing | -234.22M | -273.91M | -51.74M | -200.45M | -346.83M |
| Financing | 315.6M | 315.39M | 450.52M | 450.37M | 450.75M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Operating | -74.76M |
| Investing | -273.91M |
| Financing | 315.39M |
| Market Cap | 2.79B |
| Price to Earnings Ratio | -33.21 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 23.58 |
| Price to Book Ratio | 7.34 |
| Dividend Yield | - |
| Shares Outstanding | 58.51M |
| Average Volume (1 week) | 520.06k |
| Average Volume (1 Month) | 618.21k |
| 52 Week Change | 99.71% |
| 52 Week High | 72.29 |
| 52 Week Low | 23.7125 |
| Spread (Intraday) | 8.86 (16.72%) |
| Company Name | Apogee Therapeutics Inc |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.apogeetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
